$13.04
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Third Harmonic Bio (THRD) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestThird Harmonic Bio (NASDAQ:THRD) Stock Quotes, Forecast and News Summary
Third Harmonic Bio Stock (NASDAQ: THRD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Third Harmonic Bio (THRD) stock?
You can purchase shares of Third Harmonic Bio (NASDAQ:THRD) through any online brokerage.
Who are Third Harmonic Bio (THRD) competitors?
Other companies in Third Harmonic Bio’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for Third Harmonic Bio (THRD) stock?
Third Harmonic Bio has a consensus price target of $16.15.
What is the current price for Third Harmonic Bio (THRD)?
The stock price for Third Harmonic Bio (NASDAQ: THRD) is $13.04 last updated October 1, 2024 at 4:00 PM EDT.
Does Third Harmonic Bio (THRD) pay a dividend?
A quarterly cash dividend of 0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on August 15, 2014 to stockholders of record on August 6, 2014.
When is Third Harmonic Bio (NASDAQ:THRD) reporting earnings?
Third Harmonic Bio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Third Harmonic Bio (THRD) going to split?
There is no upcoming split for Third Harmonic Bio.
What sector and industry does Third Harmonic Bio (THRD) operate in?
Third Harmonic Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.